Confluence Wealth Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.78M Buy
38,846
+10,816
+39% +$2.33M 0.28% 51
2026
Q1
$6.1M Buy
28,030
+3,977
+17% +$882K 0.24% 58
2025
Q4
$5.5M Sell
24,053
-376
-2% -$85.7K 0.23% 57
2025
Q3
$5.66M Buy
24,429
+1,097
+5% +$223K 0.28% 52
2025
Q2
$4.33M Sell
23,332
-555
-2% -$103K 0.24% 54
2025
Q1
$4.23M Buy
23,887
+7,379
+45% +$1.43M 0.27% 53
2024
Q4
$2.82M Buy
16,508
+1,523
+10% +$280K 0.18% 64
2024
Q3
$2.96M Sell
14,985
-4,668
-24% -$871K 0.22% 57
2024
Q2
$3.37M Buy
19,653
+1,192
+6% +$197K 0.27% 47
2024
Q1
$3.36M Buy
18,461
+1,950
+12% +$336K 0.3% 46
2023
Q4
$2.56M Hold
16,511
0.28% 52
2023
Q3
$2.46M Buy
16,511
+139
+0.8% +$20.4K 0.49% 38
2023
Q2
$2.21M Buy
16,372
+25
+0.2% +$3.67K 0.47% 42
2023
Q1
$2.61M Buy
16,347
+377
+2% +$57.6K 0.61% 35
2022
Q4
$2.58M Sell
15,970
-27
-0.2% -$4.14K 0.67% 35
2022
Q3
$2.15M Sell
15,997
-10,219
-39% -$1.47M 0.91% 29
2022
Q2
$3.72M Buy
26,216
+2,705
+12% +$413K 1.64% 3
2022
Q1
$3.81M Buy
23,511
+3,042
+15% +$442K 1.38% 11
2021
Q4
$2.77M Buy
+20,469
New +$2.42M 0.89% 18

Other funds holding ABBV

Confluence Wealth Services's ABBV Position: Q2 2026 in Review

Confluence Wealth Services increased its AbbVie (ABBV) stake by 39% in Q2 2026, buying an estimated $2.33M and bringing the position to 38,846 shares worth $9.78M. The position accounts for 0.28% of the portfolio, ranked #51.

Confluence Wealth Services first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Confluence Wealth Services held 38,846 shares of AbbVie worth $9.78M as of Q2 2026.
  • Confluence Wealth Services bought 10,816 AbbVie shares in Q2 2026, an estimated $2.33M.
  • AbbVie made up 0.28% of Confluence Wealth Services's portfolio in Q2 2026, its #51 holding.
  • Confluence Wealth Services first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.